Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose

Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose

Monoclonal antibodies have been administered to kidney transplant recipients (KTRs) with a poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS-CoV-2 has been poorly studied in this context. We assessed the T cell response to SARS-CoV-2 in 97 patients on the day of t...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Dominique Bertrand, Charlotte Laurent, Mathilde Lemoine, Ludivine Lebourg, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Diana Pruteanu, Steven Grange, Tristan De Nattes, Véronique Lemée, Dominique Guerrot, Sophie Candon
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2024-04-01
Schriftenreihe:Microorganisms
Schlagworte:
belatacept
kidney transplantation
COVID-19
cellular immune response
ELISPOT
Online Zugang:https://www.mdpi.com/2076-2607/12/4/722

Online

https://www.mdpi.com/2076-2607/12/4/722

Ähnliche Einträge